An updated version should consider the changes in the nicotine market since 2001. Read More
The firm aims to support clients through their whole ‘product life cycle journey.’Read More
Altria discontinued its Verven oral tobacco product three years ago. Read More
Performance was driven by sales of IQOS and share gains for combustible products.Read More
The company is also exploring the potential for reduced-risk products in Egypt. Read More
100 experts are asking the health body to include harm reduction in its deliberations. Read More
But Nicotine & Tobacco Research will not consider industry submissions. Read More
It could be some time before the FDA issues marketing orders for flavored vapor products.Read More
The company claims the FDA retroactively changed the requirements for applications. Read More
Knowledge·Action·Change launches a series of briefing papers ahead of COP9. Read More
